Keyphrases
Humoral Response
100%
Hemodialysis Patients
100%
Third Dose
100%
BNT162b2 COVID-19 Vaccine
100%
Antibody Level
57%
Seropositivity Rate
42%
Antibody Response
28%
Booster Dose
28%
S1-RBD
28%
Immune Response
14%
Second Dose
14%
High Risk
14%
Multivariate Analysis
14%
Hypoalbuminemia
14%
Univariate Analysis
14%
Healthcare Workers
14%
High Response
14%
High Responder
14%
Neutralizing Antibodies
14%
Vaccination Protocols
14%
Serologic
14%
Two-dose
14%
Serological Response
14%
Dialysis Patients
14%
COVID-19
14%
Dialysis Treatment
14%
MRNA Vaccine
14%
BNT162b2 Vaccine
14%
Severe COVID-19 Disease
14%
RBD-IgG
14%
Two-dose Vaccination
14%
Medicine and Dentistry
Hemodialysis
100%
Humoral Immunity
100%
COVID-19 Vaccine
100%
Booster Dose
28%
Antibody Response
28%
Prospective Study
14%
Multivariate Analysis
14%
Univariate Analysis
14%
Immune Response
14%
Hypoalbuminemia
14%
Neutralizing Antibody
14%
Renal Replacement Therapy
14%
COVID-19
14%
Severe Acute Respiratory Syndrome
14%
mRNA Vaccine
14%
Diseases
14%
Immunology and Microbiology
Humoral Immunity
100%
Hemodialysis
100%
COVID-19
100%
Seropositivity
42%
Antibody Response
28%
Booster Dose
28%
Neutralizing Antibody
14%
Severe Acute Respiratory Syndrome
14%
Immune Response
14%
Biochemistry, Genetics and Molecular Biology
Hemodialysis
100%
Humoral Immunity
100%
Antibody Response
28%
Hypoalbuminemia
14%
Multivariate Analysis
14%
Immune Response
14%
Prospective Study
14%
Neutralizing Antibody
14%
Messenger RNA
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
COVID-19 Vaccine
100%
Prospective Study
14%
Hypoalbuminemia
14%
Neutralizing Antibody
14%
Severe Acute Respiratory Syndrome
14%
mRNA Vaccine
14%
Diseases
14%